Myriad Genetics to Acquire Precise Tumor, Precise Liquid
SALT LAKE CITY, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today...
Stay updated with breaking news from Genetics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SALT LAKE CITY, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today...
/PRNewswire/ -- The Consumer Genomics Market is projected to grow from US$ 1.23 billion in 2023 and is estimated to reach US$ 4.38 billion by 2031; it is...
/PRNewswire/ -- The "Auto-Immune Diseases Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies,...
Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) shares shot up 2.7% on Thursday . The company traded as high as $18.76 and last traded at $18.73. 139,980 shares were traded during mid-day trading, a decline of 73% from the average session volume of 523,469 shares. The stock had previously closed at $18.24. Wall Street […]
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero